It is estimated that over 7 million people are living with Alzheimer's Disease in Europe, and there is increasing concern about the ability to combat the disease with Europe's ageing population. In this series of articles, Euractiv will explore the state …
In my role I look at a lot of dashboards, like the one I read perhaps daily showing whether patients across Europe are able to access a new treatment following its approval by the European Medicines Agency (EMA), the medicine regulator.
